Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: ENA Respiratory Series B for Intranasal INNA-051

Lucid Diligence Brief: ENA Respiratory Series B for intranasal INNA-051…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Lilly to acquire Adverum Biotechnologies

Lucid Diligence Brief: Lilly to acquire Adverum Biotechnologies Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Wa’ed Ventures Kure Cells pre-Series A

Lucid Diligence Brief: Wa’ed Ventures Kure Cells pre-Series A Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Electra Therapeutics $183M Series C

Lucid Diligence Brief: Electra Therapeutics $183M Series C Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Takeda and Innovent global oncology partnership

Lucid Diligence Brief: Takeda and Innovent global oncology partnership…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Ipsen to acquire ImCheck Therapeutics

Lucid Diligence Brief: Ipsen to acquire ImCheck Therapeutics Professional…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: Hologic acquisition by Blackstone and TPG

Lucid Diligence Brief: Hologic acquisition by Blackstone and TPG Professional…


Lucid Diligence Brief - Tech

Lucid Diligence Brief: HealthVerity and Claritas Rx partnership

Lucid Diligence Brief: HealthVerity and Claritas Rx partnership Professional…


Artificial_Intelligence

AI in Healthcare and Digital Health Video Recap — October 20, 2025

This biweekly video summary highlights global updates in AI in Healthcare and…


Artificial_Intelligence

AI in Healthcare and Digital Health Today — October 20, 2025

From smarter diagnostics to data-driven decision-making, this weekly roundup…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Pelage Pharmaceuticals $120M Series B

Lucid Diligence Brief: Pelage Pharmaceuticals $120M Series B Professional…


Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Kardigan $254m Series B

Lucid Diligence Brief: Kardigan $254m Series B Professional audiences only. Not…


Privacy Preference Center